- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| RAPID DOSE THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 19.02. | Rapid Dose Therapeutics Corp: Rapid Dose arranges $5-million private placement | 2 | Stockwatch | ||
| 19.02. | Rapid Dose Therapeutics announces proposed equity private placement financing | 1 | Seeking Alpha | ||
| 18.02. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Corp Announces Proposed Equity Private Placement Financing | 354 | Newsfile | Burlington, Ontario--(Newsfile Corp. - February 18, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement... ► Artikel lesen | |
| 29.01. | PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics intensiviert Zusammenarbeit mit Weltmarktführer im Bereich der oralen Nikotinprodukte - zur Vorbereitung der Markteinführung von QuickStrip® Nicotine | 248 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics intensiviert Zusammenarbeit mit Weltmarktführer im Bereich der oralen Nikotinprodukte - zur Vorbereitung der Markteinführung von... ► Artikel lesen | |
| 29.01. | Rapid Dose Therapeutics Corp: Rapid Dose continues deal with nicotine firm | 3 | Stockwatch | ||
| 29.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Advances Collaboration with Global Leader for Market-Ready QuickStrip(R) Nicotine in 2025 | 414 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (RDT), a Canadian biotechnology company working with an international company in oral nicotine products... ► Artikel lesen | |
| 28.01. | Rapid Dose Therapeutics Corp: Rapid Dose receives extension for debt settlement | 8 | Stockwatch | ||
| 27.01. | Rapid Dose Therapeutics receives extension to close its shares-for-debt deal | 3 | Seeking Alpha | ||
| 27.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Provides Update on Share Issuance in Debt Settlement with Creditors and Proposed Private Placement | 350 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated December 9, 2024... ► Artikel lesen | |
| 16.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Completes Issuance of Shares as Payment of Directors' Fees | 179 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 16, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has completed its previously announced shares... ► Artikel lesen | |
| 08.01. | Rapid Dose Therapeutics Corp: Rapid Dose to issue 430,930 shares as interest payment | 4 | Stockwatch | ||
| 07.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt | 369 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 24.12.24 | Rapid Dose Therapeutics Corp: Rapid Dose to issue shares for director fees | 3 | Stockwatch | ||
| 24.12.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees | 372 | Newsfile | Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors")... ► Artikel lesen | |
| 11.12.24 | Rapid Dose Therapeutics Corp: Rapid Dose arranges $6-million private placement | 8 | Stockwatch | ||
| 10.12.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Equity Private Placement Financing and Proposed Shares for Debt Settlement | 420 | Newsfile | Burlington, Ontario--(Newsfile Corp. - December 10, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement... ► Artikel lesen | |
| 06.12.24 | Rapid Dose Therapeutics Corp: Rapid Dose applies for patent on Lidocaine film strip | 1 | Stockwatch | ||
| 05.12.24 | Rapid Dose Therapeutics Corp. Files Patent Application for Lidocaine Oral Thin Strip | 278 | Newsfile | Burlington, Ontario--(Newsfile Corp. - December 5, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company, is pleased to announce that it has filed... ► Artikel lesen | |
| 30.10.24 | Rapid Dose Therapeutics Corp: Rapid Dose closes final tranche of financing | 1 | Stockwatch | ||
| 30.10.24 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Closing of Final Tranche of Common Share Private Placement | 386 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 30, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a second and final tranche of... ► Artikel lesen |
Seite:
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 107,60 | +0,75 % | Achtung - BioTech startet durch! Evotec, Vidac Pharma, BioNTech und Novo Nordisk im Fokus | Mit täglich neuen Index-Höchstständen und riesigen Börsenumsätzen, steht der BioTech-Sektor nun seit einigen Wochen auch wieder im Fokus. Bei Evotec dreht sich das Personalkarussell weiter, BioNTech... ► Artikel lesen | |
| CLINUVEL | 7,175 | -0,42 % | CLINUVEL PHARMACEUTICALS LIMITED: CLINUVEL Unveils Vitiligo Program for AAD 2025 | ||
| BIONXT SOLUTIONS | 0,381 | -7,52 % | Bayer, BioNxt Solutions, Evotec - Künstliche Intelligenz als Gamechanger in der Pharmaforschung | Neue Technologien und innovative Lösungen werden die Medizin der Zukunft komplett verändern. Um sich bestmöglich darauf vorzubereiten, müssen Hürden wie Bürokratie, Geldprobleme oder veraltete Strukturen... ► Artikel lesen | |
| AMYRIS | - | - | BioMaP-Consortium Contracts Amyris to Support Domestic Medicines Supply | ||
| ATAI LIFE SCIENCES | 1,450 | +1,65 % | ICE - ATAI Life Sciences - Das war einfach! - Vorher, nachher | ||
| VIDAC PHARMA | 0,640 | 0,00 % | Vidac Pharma präsentiert innovative Ansätze in der Onkologie | ||
| SOL GLOBAL INVESTMENTS | 0,121 | +3,42 % | SOL Global Investments Corp.: SOL Global Announces Additional Solana Token Acquisition and Applauds President Trump's Commitment to Solana as a Strategic Digital Asset | Toronto, Ontario--(Newsfile Corp. - March 3, 2025) - SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) ("SOL Global" or the "Company"), one of the first publicly traded companies... ► Artikel lesen | |
| MUSTGROW BIOLOGICS | 0,784 | +1,29 % | MustGrow Biologics Corp.: MustGrow Signs Exclusive Distribution Agreement with Adjuvants Plus Inc. for Biological Product Line | Saskatoon, Saskatchewan--(Newsfile Corp. - February 11, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative... ► Artikel lesen | |
| ENTHEON BIOMEDICAL CORP | 0,170 | -12,82 % | Entheon Biomedical Corp.: Entheon Announces Agreement to Acquire Mentis AI | Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered... ► Artikel lesen | |
| CARA THERAPEUTICS | 4,610 | -100,00 % | XFRA 69C0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCARA THERAPEUTICS... ► Artikel lesen | |
| REVIVE THERAPEUTICS | 0,004 | +600,00 % | Revive Therapeutics Ltd: Revive to buy molecular hydrogen rights from Diagnamed | ||
| CYBIN | 7,200 | +3,60 % | Cybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025 | ||
| AWAKN LIFE SCIENCES | 0,074 | -100,00 % | Awakn Life Sciences Corp.: Awakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plc | Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing... ► Artikel lesen | |
| ARTELO BIOSCIENCES | 1,060 | 0,00 % | Artelo Biosciences Provides Business Update and Reports Fiscal 2024 Year-End Financial Results | SOLANA BEACH, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop... ► Artikel lesen | |
| LOBE SCIENCES | 0,013 | +38,89 % | Lobe Sciences Ltd (2): Lobe Sciences receives U.S. Conjugated Psilocin patent |
Das Unternehmen RAPID DOSE THERAPEUTICS CORP kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAPID DOSE THERAPEUTICS CORP finden Sie auf Wallstreet Online.
